News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
824,121 Results
Type
Article (85253)
Company Profile (622)
Press Release (738246)
Section
Business (231829)
Career Advice (4090)
Deals (39621)
Drug Delivery (106)
Drug Development (90416)
Employer Resources (192)
FDA (17878)
Job Trends (17246)
News (394564)
Policy (39583)
Tag
Academia (2973)
Africa (1262)
Alliances (56326)
Alzheimer's disease (1241)
Approvals (17792)
Arizona (209)
Artificial intelligence (85)
Asia (48985)
Australia (8613)
Bankruptcy (392)
Best Places to Work (12243)
Biotechnology (436)
C2C Services and Suppliers (95129)
California (1955)
Canada (926)
Cancer (490)
Career advice (3497)
Cell therapy (139)
China (149)
Clinical research (70363)
Collaboration (146)
Colorado (80)
Compensation (79)
Connecticut (80)
COVID-19 (2753)
Cystic fibrosis (77)
Data (272)
Diabetes (89)
Diagnostics (6495)
Drug pricing (81)
Earnings (93516)
Employer resources (162)
Europe (111960)
Events (124943)
Executive appointments (147)
FDA (18089)
Florida (265)
Funding (144)
Gene therapy (104)
GLP-1 (615)
Government (5004)
Healthcare (20646)
Hotbed/Location (534624)
Illinois (315)
Indiana (159)
Infectious disease (2783)
Inflammatory bowel disease (100)
Interviews (805)
IPO (17482)
Job creations (5172)
Job search strategy (2849)
Kansas (100)
Layoffs (467)
Legal (10011)
Lung cancer (114)
Manufacturing (98)
Maryland (420)
Massachusetts (1674)
Medical device (14256)
Medtech (14261)
Mergers & acquisitions (21950)
Metabolic disorders (291)
Michigan (135)
Minnesota (235)
Neuroscience (1400)
New Jersey (591)
New York (598)
NextGen Class of 2024 (7622)
Non-profit (5052)
North Carolina (695)
Northern California (824)
Obesity (173)
Ohio (110)
Opinion (234)
Patents (74)
Pennsylvania (585)
People (63690)
Pharmaceutical (119)
Phase I (21605)
Phase II (30547)
Phase III (23082)
Pipeline (106)
Podcasts (75)
Postmarket research (3532)
Preclinical (9761)
Press Release (72)
Rare diseases (140)
Real estate (7361)
Recruiting (72)
Regulatory (25582)
Research institute (2633)
Resumes & cover letters (645)
South America (1640)
Southern California (746)
Startups (4271)
Texas (251)
United States (9126)
Vaccines (561)
Washington State (275)
Weight loss (165)
Date
Today (63)
Last 7 days (714)
Last 30 days (2236)
Last 365 days (39977)
2024 (27783)
2023 (42566)
2022 (53929)
2021 (58727)
2020 (57671)
2019 (51341)
2018 (39126)
2017 (37193)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36269)
2012 (38416)
2011 (38383)
2010 (39616)
There are 824,121 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Trailhead Biosystems Announces Joshua Snow as Chief Commercial Officer
September 16, 2024
·
2 min read
Press Releases
China patent notification boosts PolTREG’s development of Treg cell therapy in multiple sclerosis
September 16, 2024
·
5 min read
Press Releases
FDA approves OCREVUS ZUNOVO™ as the first and only twice-a-year 10-minute subcutaneous injection for people with relapsing and progressive multiple sclerosis
September 16, 2024
·
9 min read
Press Releases
TORL BioTherapeutics Presents Updated Phase 1 Results of Novel Claudin 6 Targeted Antibody-Drug Conjugate TORL-1-23 at the 2024 European Society of Medical Oncology Congress
September 16, 2024
·
5 min read
Press Releases
IMFINZI® (durvalumab) perioperative regimen reduced the risk of recurrence by 32% and the risk of death by 25% vs. neoadjuvant chemotherapy alone in muscle-invasive bladder cancer in the NIAGARA Phase III trial
September 16, 2024
·
19 min read
Press Releases
KEYTRUDA® (pembrolizumab) Plus Chemotherapy Before Surgery and Continued as Single Agent After Surgery Reduced Risk of Death by More Than One-Third (34%) Versus Neoadjuvant Chemotherapy in High-Risk Early-Stage Triple-Negative Breast Cancer (TNBC)
September 16, 2024
·
19 min read
Press Releases
Scorpion Therapeutics Presents Initial Clinical Data From Its Phase 1/2 Trial of STX-478 Demonstrating Potentially Best-in-Class Mutant-Selective PI3Kα Inhibition for the Treatment of Advanced Solid Tumors at ESMO Congress 2024
September 16, 2024
·
8 min read
Press Releases
Bristol Myers Squibb Presents Landmark 10-Year Follow-Up Data from CheckMate -067 Which Showed Continued Durable Long-Term Survival Benefit with Opdivo® plus Yervoy® in Advanced Melanoma
September 16, 2024
·
19 min read
Press Releases
New Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer
September 16, 2024
·
7 min read
Press Releases
Exelixis Presents Final Overall Survival Results from Phase 3 CONTACT-02 Pivotal Study Evaluating Cabozantinib in Combination with an Immune Checkpoint Inhibitor in Metastatic Castration-Resistant Prostate Cancer at ESMO 2024
September 16, 2024
·
17 min read
1 of 82,413
Next
